An oligonucleotide decoy for Stat3 activates the immune response of macrophages to breast cancer

被引:46
作者
Sun, ZK [1 ]
Yao, ZX [1 ]
Liu, SC [1 ]
Tang, H [1 ]
Yan, X [1 ]
机构
[1] Chongqing Univ Med Sci, Affiliated Hosp 1, Dept Gen Surg, Chongqing 400016, Peoples R China
关键词
breast carcinoma; decoy oligonucleotide; rat; signal transducer and activators of transcription 3; tumor-associated macrophage;
D O I
10.1016/j.imbio.2005.11.004
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Tumor-associated macrophages (TAMs) have the potential to Induce both immune activation and immune tolerance. Recent studies have indicated that in breast cancers the pro-tumor role of TAMs is dominant. We induced rat peritoneal macrophages with rat breast cancer cell-conditioned medium and analyzed signal transducer and activators of transcription 3 (Stat3) activities of the cells. Then these cells were transfected with Stat3 decoy oligonnucleotides (ODNs) and were stimulated by lipopolysaccharide (LPS). The results demonstrate that induced macrophages displayed a reduction of cytotoxicity and antigen-presenting function in comparison with control but transfection with Stat3 decoy ODNs enhanced cytotoxicity and antigen-presenting function of the macrophages. Furthermore, injection of induced macrophages promoted tumor growth accompanied by immunosuppression in the rat tumor models, but injection or induced macrophages transfected with Stat3 decoy ODNs led to retarded tumor growth accompanied by immune activation. The data suggest that immunosuppressive activities of TAMs correlate with over-activated Stat3 signaling of the cells and disruption of Stat3 activity of TAMs can enhance rat immune response to breast cancer. (c) 2006 Elsevier GmbH. All rights reserved.
引用
收藏
页码:199 / 209
页数:11
相关论文
共 28 条
[1]   Inflammation and cancer: back to Virchow? [J].
Balkwill, F ;
Mantovani, A .
LANCET, 2001, 357 (9255) :539-545
[2]   Role of Stat3 in lipopolysaccharide-induced IL-10 gene expression [J].
Benkhart, EM ;
Siedlar, M ;
Wedel, A ;
Werner, T ;
Ziegler-Heitbrock, HWL .
JOURNAL OF IMMUNOLOGY, 2000, 165 (03) :1612-1617
[3]   The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies [J].
Bingle, L ;
Brown, NJ ;
Lewis, CE .
JOURNAL OF PATHOLOGY, 2002, 196 (03) :254-265
[4]   Tumors and inflammatory infiltrates: Friends or foes? [J].
Brigati, C ;
Noonan, DM ;
Albini, A ;
Benelli, R .
CLINICAL & EXPERIMENTAL METASTASIS, 2002, 19 (03) :247-258
[5]   Stat3 as an oncogene [J].
Bromberg, JF ;
Wrzeszczynska, MH ;
Devgan, G ;
Zhao, YX ;
Pestell, RG ;
Albanese, C ;
Darnell, JE .
CELL, 1999, 98 (03) :295-303
[6]   CCL16/LEC powerfully triggers effector and antigen-presenting functions of macrophages and enhances T cell cytotoxicity [J].
Cappello, P ;
Caorsi, C ;
Bosticardo, M ;
De Angelis, S ;
Novelli, F ;
Forni, G ;
Giovarelli, M .
JOURNAL OF LEUKOCYTE BIOLOGY, 2004, 75 (01) :135-142
[7]   A critical role for stat3 signaling in immune tolerance [J].
Cheng, FD ;
Wang, HW ;
Cuenca, A ;
Huang, M ;
Ghansah, T ;
Brayer, J ;
Kerr, WG ;
Takeda, K ;
Akira, S ;
Schoenberger, SP ;
Yu, H ;
Jove, R ;
Sotomayor, EM .
IMMUNITY, 2003, 19 (03) :425-436
[8]   Inflammation and cancer [J].
Coussens, LM ;
Werb, Z .
NATURE, 2002, 420 (6917) :860-867
[9]   STATs and gene regulation [J].
Darnell, JE .
SCIENCE, 1997, 277 (5332) :1630-1635
[10]  
DING L, 1993, J IMMUNOL, V151, P1224